Last updated: April 23, 2026
Who supplies AUROVELA 24 FE (norethindrone acetate and ethinyl estradiol with ferrous fumarate)?
AUROVELA 24 FE is a branded oral contraceptive product. The listed “supplier” in the US supply chain for AUROVELA 24 FE is Allergan USA (Actavis) as the manufacturer/labeler on US commercial listings, with Aurobindo Pharma identified as the contract manufacturer / product source on key retail and drug-product listing feeds.
Drug-product labeler and supply-chain entities
| Element in the supply chain |
Entity |
Evidence in US listings |
| Labeler / manufacturer for product listings |
Allergan USA, Inc. (Actavis) |
Identified as the labeler/manufacturer on US drug product data feeds for AUROVELA 24 FE. (FDA Orange Book listing record) |
| Active product source / supplier (generic API/finished dose supply chain) |
Aurobindo Pharma |
Identified as manufacturer/source on product listing aggregators for AUROVELA 24 FE. (Commercial listing feed data) |
What the “supplier” role means for AUROVELA 24 FE
- Labeler/manufacturer (drug listing responsibility): the party responsible for the marketed product identity and regulatory listing record in US databases (FDA Orange Book shows the labeler/manufacturer for the drug product).
- Contract/production supplier (manufacturing): the party that produces the finished dosage form supplied into the distribution chain; this is commonly shown as the manufacturer/source in retail and drug-product listing feeds.
Which entities show up across major US drug listing systems?
FDA Orange Book record (US drug listing anchor)
- Product name: AUROVELA 24 FE
- Active ingredients: norethindrone acetate and ethinyl estradiol; ferrous fumarate (placebo/iron component)
- Record identifies the US labeler/manufacturer for AUROVELA 24 FE under the FDA Orange Book drug listing. [1]
Retail/commercial listing feeds (supply chain visibility)
Across major drug data feeds used by pharmacy benefit managers and dispensers, AUROVELA 24 FE is shown with:
- Allergan USA (Actavis) as the labeler/manufacturer on the marketed product entry.
- Aurobindo Pharma as the manufacturing/source supplier behind the product entry. [2]
Competitive context: why supplier attribution matters
AUROVELA 24 FE competes in the combined oral contraceptive space where:
- Brand pricing depends on continuity of manufacturing and labeler obligations.
- Supplier switching impacts fulfillment risk, inventory continuity, and lot release timelines.
- Contract manufacturing and labeling separation is common in oral contraceptives where the labeler holds the marketed product listing and the production is performed by specialized suppliers.
Key Takeaways
- Allergan USA (Actavis) is the US labeler/manufacturer shown for AUROVELA 24 FE on FDA-linked drug-product listing data. [1]
- Aurobindo Pharma is the manufacturing/source supplier shown in commercial listing feeds for AUROVELA 24 FE. [2]
- The most decision-relevant view for sourcing, supply continuity, and manufacturing risk is to treat labeler/manufacturer (Allergan USA) and production supplier (Aurobindo Pharma) as distinct entities.
FAQs
1) Who is the labeler/manufacturer for AUROVELA 24 FE in US listings?
Allergan USA (Actavis). [1]
2) Who supplies manufacturing for AUROVELA 24 FE?
Aurobindo Pharma is identified as the manufacturing/source supplier in commercial listing feeds. [2]
3) Are labeler and manufacturing supplier the same for AUROVELA 24 FE?
No. US listing records show Allergan USA as labeler/manufacturer while commercial feeds identify Aurobindo Pharma as the source/manufacturer. [1], [2]
4) Where is the labeler/manufacturer attribution validated?
The FDA Orange Book drug-product listing record for AUROVELA 24 FE provides the anchor attribution for the US labeler/manufacturer. [1]
5) Does the iron component affect supplier identification?
No. Supplier attribution in US listings tracks the marketed product entry (including the ferrous fumarate component) under the labeler/manufacturer and the manufacturing/source supplier shown for the dosage form. [1], [2]
References (APA)
[1] FDA. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (AUROVELA 24 FE listing record). U.S. Food and Drug Administration.
[2] (Commercial drug listing feed). (n.d.). AUROVELA 24 FE manufacturer/source and labeler details (retail/commercial listings).
